Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dewpoint Therapeutics selects a first-in-class small molecule development candidate for multiple cancers in which MYC dependence is a central driver.
-
Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "EZH2 Targeted Therapy Market Opportunity, Approved Drug Price, Sales and Clinical Trials Insight 2026" report has been added to ...
-
Carterra launches Vega™, the industry’s first 48-channel HT-SPR platform, enabling high-resolution, label-free primary screening for modern drug discovery.
-
Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Continuous Manufacturing for Small Molecule APIs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
-
Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.Global...
-
Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "China's Licensing Trends Shaping Global Drug Development" report has been added to ResearchAndMarkets.com's offering.Over the past five years, China's...
-
Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's...
-
Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Abemaciclib Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The abemaciclib market size has grown rapidly in recent...
-
Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Company Size, Scale of Operation,...
-
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of IGF-1R- and IGF-1 Targeted Immunotherapy" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...